The weekly litigation news digest is live. Subscribe now

Formulation For Anti- 4 7 Antibody

Patent No. EP2704742 (titled "Formulation For Anti- 4 7 Antibody") was filed by Millennium Pharmaceuticals on May 2, 2012. The application was issued on Jul 12, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DEHMEL & BETTENHAUSENApr 12, 2018RUCKERL
GILL JENNINGS & EVERYApr 12, 2018GILL JENNINGS & EVERY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2704742

MILLENNIUM PHARMACEUTICALS
Application Number
EP12722973A
Filing Date
May 2, 2012
Status
Revoked
Dec 19, 2022
Publication Date
Jul 12, 2017